Overexpression of the Promigratory and Prometastatic PTK7 Receptor Is Associated with an Adverse Clinical Outcome in Colorectal Cancer

• Anne-Catherine Lhoumeau ,

  Contributed equally to this work with: Anne-Catherine Lhoumeau, Sébastien Martinez

  Affiliations CRCM, Team Cell Polarity, Cell signalling and Cancer “Equipe labellisée Ligue Contre le Cancer”, Inserm, U1068, Marseille, F-13009, France, Institut Paoli-Calmettes, Marseille, F-13009, France, Aix-Marseille Université, Marseille, F-13284, France, CNRS, UMR7258, F-13009, Marseille, France, Department of Biopathology, Institut Paoli-Calmettes, Marseille, France

  ⨯
• Sébastien Martinez ,

  Contributed equally to this work with: Anne-Catherine Lhoumeau, Sébastien Martinez

  Affiliations CRCM, Team Cell Polarity, Cell signalling and Cancer “Equipe labellisée Ligue Contre le Cancer”, Inserm, U1068, Marseille, F-13009, France, Institut Paoli-Calmettes, Marseille, F-13009, France, Aix-Marseille Université, Marseille, F-13284, France, CNRS, UMR7258, F-13009, Marseille, France

  ⨯
• Jean-Marie Boher,

  Affiliations Institut Paoli-Calmettes, Marseille, F-13009, France, Department of Biostatistics, Institut Paoli-Calmettes, Marseille, France

  ⨯
• Geneviève Monges,

  Affiliations Institut Paoli-Calmettes, Marseille, F-13009, France, Department of Biopathology, Institut Paoli-Calmettes, Marseille, France

  ⨯
• Rémy Castellano,

  Affiliations CRCM, Team Cell Polarity, Cell signalling and Cancer “Equipe labellisée Ligue Contre le Cancer”, Inserm, U1068, Marseille, F-13009, France, Institut Paoli-Calmettes, Marseille, F-13009, France, Aix-Marseille Université, Marseille, F-13284, France, CNRS, UMR7258, F-13009, Marseille, France

  ⨯
• Armelle Goubard,

  Affiliations CRCM, Team Cell Polarity, Cell signalling and Cancer “Equipe labellisée Ligue Contre le Cancer”, Inserm, U1068, Marseille, F-13009, France, Institut Paoli-Calmettes, Marseille, F-13009, France, Aix-Marseille Université, Marseille, F-13284, France, CNRS, UMR7258, F-13009, Marseille, France

  ⨯
• Marie Doremus,

  Affiliations CRCM, Team Cell Polarity, Cell signalling and Cancer “Equipe labellisée Ligue Contre le Cancer”, Inserm, U1068, Marseille, F-13009, France, Institut Paoli-Calmettes, Marseille, F-13009, France, Aix-Marseille Université, Marseille, F-13284, France, CNRS, UMR7258, F-13009, Marseille, France

  ⨯
• Flora Poizat,

  Affiliations Institut Paoli-Calmettes, Marseille, F-13009, France, Department of Biopathology, Institut Paoli-Calmettes, Marseille, France

  ⨯
• Bernard Lelong,

  Affiliations Institut Paoli-Calmettes, Marseille, F-13009, France, Department of Surgical Oncology, Institut Paoli-Calmettes, Marseille, France

  ⨯
• Cécile de Chaisemartin,

  Affiliations Institut Paoli-Calmettes, Marseille, F-13009, France, Department of Surgical Oncology, Institut Paoli-Calmettes, Marseille, France

  ⨯
• Florence Bardin,

  Affiliations CRCM, Team Cell Polarity, Cell signalling and Cancer “Equipe labellisée Ligue Contre le Cancer”, Inserm, U1068, Marseille, F-13009, France, Institut Paoli-Calmettes, Marseille, F-13009, France, Aix-Marseille Université, Marseille, F-13284, France, CNRS, UMR7258, F-13009, Marseille, France

  ⨯
• Patrice Viens,

  Affiliations CRCM, Team Cell Polarity, Cell signalling and Cancer “Equipe labellisée Ligue Contre le Cancer”, Inserm, U1068, Marseille, F-13009, France, Institut Paoli-Calmettes, Marseille, F-13009, France, Aix-Marseille Université, Marseille, F-13284, France, CNRS, UMR7258, F-13009, Marseille, France, Department of Medical Oncology, Institut Paoli-Calmettes, Marseille, France

  ⨯
• Jean-Luc Raoul,

  Affiliations CRCM, Team Cell Polarity, Cell signalling and Cancer “Equipe labellisée Ligue Contre le Cancer”, Inserm, U1068, Marseille, F-13009, France, Institut Paoli-Calmettes, Marseille, F-13009, France, Aix-Marseille Université, Marseille, F-13284, France, CNRS, UMR7258, F-13009, Marseille, France, Department of Medical Oncology, Institut Paoli-Calmettes, Marseille, France

  ⨯
• Thomas Prebet,

  Affiliations CRCM, Team Cell Polarity, Cell signalling and Cancer “Equipe labellisée Ligue Contre le Cancer”, Inserm, U1068, Marseille, F-13009, France, Institut Paoli-Calmettes, Marseille, F-13009, France, Aix-Marseille Université, Marseille, F-13284, France, CNRS, UMR7258, F-13009, Marseille, France, Department of Hematology, Institut Paoli-Calmettes, Marseille, France

  ⨯
• Michel Aurrand-Lions,

  Affiliations CRCM, Team Cell Polarity, Cell signalling and Cancer “Equipe labellisée Ligue Contre le Cancer”, Inserm, U1068, Marseille, F-13009, France, Institut Paoli-Calmettes, Marseille, F-13009, France, Aix-Marseille Université, Marseille, F-13284, France, CNRS, UMR7258, F-13009, Marseille, France

  ⨯
• Jean-Paul Borg ,

  ¶‡ These authors both supervised this work.

  Affiliations CRCM, Team Cell Polarity, Cell signalling and Cancer “Equipe labellisée Ligue Contre le Cancer”, Inserm, U1068, Marseille, F-13009, France, Institut Paoli-Calmettes, Marseille, F-13009, France, Aix-Marseille Université, Marseille, F-13284, France, CNRS, UMR7258, F-13009, Marseille, France

  ⨯
•  [ ... ],
• Anthony Gonçalves

  * E-mail: goncalvesa@ipc.unicancer.fr

  ¶‡ These authors both supervised this work.

  Affiliations CRCM, Team Cell Polarity, Cell signalling and Cancer “Equipe labellisée Ligue Contre le Cancer”, Inserm, U1068, Marseille, F-13009, France, Institut Paoli-Calmettes, Marseille, F-13009, France, Aix-Marseille Université, Marseille, F-13284, France, CNRS, UMR7258, F-13009, Marseille, France, Department of Medical Oncology, Institut Paoli-Calmettes, Marseille, France

  ⨯
• [ view all ]
• [ view less ]